1. Anti-inflammation mechanisms of a homogeneous polysaccharide from Phyllanthus emblica L. on DSS induced colitis mice via the gut microbiota and metabolites alteration.
- Author
-
Li X, Chen Y, Peng X, Zhu Y, Duan W, Ji R, Xiao H, Li X, Liu G, Yu Y, and Cao Y
- Subjects
- Animals, Mice, Male, Humans, Mice, Inbred C57BL, Colitis chemically induced, Colitis drug therapy, Colitis metabolism, Colitis microbiology, Disease Models, Animal, Colon microbiology, Colon drug effects, Colon metabolism, Colon immunology, Gastrointestinal Microbiome drug effects, Dextran Sulfate adverse effects, Polysaccharides pharmacology, Polysaccharides chemistry, Polysaccharides administration & dosage, Polysaccharides isolation & purification, Phyllanthus emblica chemistry, Anti-Inflammatory Agents pharmacology, Anti-Inflammatory Agents chemistry, Anti-Inflammatory Agents administration & dosage, Colitis, Ulcerative drug therapy, Colitis, Ulcerative chemically induced, Colitis, Ulcerative microbiology, Colitis, Ulcerative metabolism, Bacteria classification, Bacteria isolation & purification, Bacteria drug effects, Bacteria genetics, Plant Extracts pharmacology, Plant Extracts chemistry, Plant Extracts administration & dosage
- Abstract
Phyllanthus emblica L. offers promising therapeutic potential for inflammatory diseases. This study revealed the molecular structure of a homogeneous polysaccharide purified from Phyllanthus emblica L. (PEP-1) and evaluated its anti-inflammatory effects on ulcerative colitis (UC) in mice. In the in vivo experiment, administered in varying dosages to dextran sulfate sodium (DSS)-induced UC models, PEP-1 significantly alleviated colonic symptoms, histological damages and reshaped the gut microbiota. Notably, it adjusted the Firmicutes/Bacteroidetes ratio and reduced pro-inflammatory species, closely aligning with shifts in the fecal metabolites and metabolic pathways such as the metabolism of pyrimidine, beta-alanine, and purine. These findings underscore the potential of PEP-1 as a therapeutic agent for UC, providing insights into the mechanisms through gut microbiota and metabolic modulation., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier Ltd. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF